Does a screening digital rectal exam provide actionable clinical utility in patients with an elevated PSA and positive MRI?-Reference-Cited by-同舟云学术

Does a screening digital rectal exam provide actionable clinical utility in patients with an elevated PSA and positive MRI?

Published:2021-05-04 Issue: Volume: Page:
ISSN:2688-4526
Container-title:BJUI Compass
language:en
Short-container-title:BJUI Compass

Author:

Chang Courtney M.¹²^ORCID,McIntosh Andrew G.²,Shapiro Daniel D.²^ORCID,Davis John W.²,Ward John F.²,Gregg Justin R.¹²^ORCID

Affiliation:

1. McGovern Medical School University of Texas Houston TX USA

2. The University of Texas MD Anderson Cancer Center Houston TX USA

Publisher

Wiley

Subject

Religious studies,Cultural Studies

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/bco2.69

Reference31 articles.

1. Clinically localized prostate cancer: AUA/ASTRO/SUO guideline. Part I: Risk stratification, shared decision making, and care options;Sanda MG;J Urol,2018

2. MottetN BellmuntJ BriersE BollaM BourkeL CornfordP et al. Members of the EAU—ESTRO—ESUR—SIOG prostate cancer guidelines panel. EAU—ESTRO—ESUR—SIOG guidelines on prostate cancer. Edn. Presented at the EAU Annual Congress Amsterdam 2020. 978–94‐92671‐07‐3.EAU Guidelines Office Arnhem The Netherlands.

3. Measurement of prostate‐specific antigen in serum as a screening test for prostate cancer;Catalona WJ;N Engl J Med,1991

4. Comparison of MR/ultrasound fusion‐guided biopsy with ultrasound‐guided biopsy for the diagnosis of prostate cancer;Siddiqui MM;JAMA,2015

5. Yearly prostate specific antigen and digital rectal examination fluctuations in a screened population;Ankerst DP;J Urol,2009

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prostate cancer grading framework based on deep transfer learning and Aquila optimizer;Neural Computing and Applications;2024-02-22

2. Prostate-specific antigen density as the best predictor of low- to intermediate-risk prostate cancer: a cohort study;Translational Cancer Research;2023-03

3. Predictors of Clinically Significant Prostate Cancer in Patients with PIRADS Categories 3–5 Undergoing Magnetic Resonance Imaging-Ultrasound Fusion Biopsy of the Prostate;Journal of Clinical Medicine;2022-12-25

4. A prostate biopsy risk calculator based on MRI : development and comparison of the Prospective Loyola University multiparametric MRI (PLUM) and Prostate Biopsy Collaborative Group (PBCG) risk calculators;BJU International;2022-07-11

5. Magnetic resonance imaging–based risk calculators optimize selection for prostate biopsy among biopsy‐naive men;Cancer;2021-08-24